ORBIS receive $5 million from AIG

Article

ORBIS International has been awarded a $5,000,000 grant from American International Group (AIG) to ensure the growth of its long-term blindness prevention programmes in the developing world.

ORBIS International has been awarded a $5,000,000 grant from American International Group (AIG) to ensure the growth of its long-term blindness prevention programmes in the developing world.

Initially the grant will be devoted to combating blindness in China, India and Vietnam by providing sustainable eye care services. Projects will focus on the practical, systemic challenges facing service providers, such as improving rural services in Vietnam, developing paediatric ophthalmology centres in India and sustaining affordable rural eye care services in western China.

By awarding this money, AIG joins founding members Alcon and FedEx in the ORBIS Alliance for Sight and is designated a Global Sponsor.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.